Trial Profile
Pharmacodynamic study of edoxaban in patients with non-valvular atrial fibrillation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Stroke
- Focus Pharmacodynamics
- 03 Feb 2016 New trial record
- 27 Jan 2016 Results published in the Circulation Journal